Company news
Mimedx Group, Inc (NASDAQ:MDXG) news
Every Mimedx Group, Inc press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
July 29, 2026
MIMEDX to Acquire Sanara MedTech
July 29, 2026
MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29
July 20, 2026
MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
May 21, 2026
MIMEDX Announces Launch of G4Derm® Plus
May 8, 2026
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Pro...
April 30, 2026
MIMEDX Announces First Quarter 2026 Operating & Financial Results
April 29, 2026
MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29
April 22, 2026
MIMEDX Announces Restructuring and Cost Reduction Initiative
April 16, 2026
MIMEDX to Sponsor Leading Advanced Wound Care Conferences
April 2, 2026
MIMEDX Announces Launch of CHORIOFIX™
March 23, 2026
MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields
March 5, 2026
MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results
February 25, 2026
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
February 17, 2026
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products
February 4, 2026
MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®
February 2, 2026
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel
December 22, 2025
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membr...
December 19, 2025
MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial
November 13, 2025
MIMEDX to Participate in Upcoming Investor Conferences
November 10, 2025
MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule
November 3, 2025
MIMEDX Announces Record Revenue for Third Quarter 2025
October 29, 2025
MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29
October 15, 2025
MIMEDX Announces Launch of EPIXPRESS®
October 6, 2025
MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall
September 3, 2025
MIMEDX Announces Strategic Collaboration with Vaporox, Inc.
July 30, 2025
MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results
July 30, 2025
MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30
July 16, 2025
MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026
July 15, 2025
MIMEDX to Present at the BofA Securities 2025 Healthcare Conference
May 6, 2025
MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)
May 5, 2025
MIMEDX Announces First Quarter 2025 Operating and Financial Results
April 30, 2025
MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30
April 16, 2025
MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences
April 10, 2025
MIMEDX to Present at TD Cowen 45th Annual Health Care Conference
February 27, 2025
MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results
February 26, 2025
MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26
February 5, 2025
MIMEDX Files Patent Infringement Lawsuit Against Surgenex
December 17, 2024
MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs
November 14, 2024
MIMEDX Announces Third Quarter 2024 Operating and Financial Results
October 30, 2024
MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30
October 14, 2024
MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue
October 8, 2024
MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall
October 1, 2024
MIMEDX Announces Second Quarter 2024 Operating and Financial Results
July 31, 2024
MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix
July 31, 2024
MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports
July 22, 2024
MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31
July 17, 2024
MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer
June 26, 2024
MIMEDX Announces First Quarter 2024 Operating and Financial Results
April 30, 2024
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
April 16, 2024